Latest news

12 October 2026

Eni sells stakes in selected Indonesian upstream assets to Pertamina and Medco

Two binding agreements transfer 10% interests across multiple Indonesian PSCs, covering producing gas fields, major discoveries and hub projects; completions subject to regulatory approvals.
12 October 2026

ITM Power's Hydropulse signs Heads of Terms for 150 MW green hydrogen project with European refinery

A 150 MW Alpha electrolyser plant will supply green hydrogen under a planned 10-year contract; FEED is underway with FID targeted in 2027 and production expected in 2029.
12 October 2026

CATL becomes first battery company with Battery Passports in all three GBA pilot waves

Achieved comprehensive ESG data coverage across the battery value chain; participated since 2023; 2026 pilot included cell makers representing nearly 80% of global capacity.
12 October 2026

Technip Energies wins HPCL EPC for Mumbai lube modernisation

Two large refining units (550 KTA IHCD and 850 KTA SDA) will be integrated into the operating Mumbai Refinery to modernise lube base‑stock production and upgrade heavy streams.
11 October 2026

Brenntag and Givaudan expand Active Beauty distribution to Australia and New Zealand

Brings cosmetic actives and specialty ingredients to Australia and New Zealand, paired with local distribution, technical formulation support and Innovation & Application Centers.
10 October 2026

CATL and SERES deepen strategic partnership with >20 GWh joint battery capacity plan

Deal secures CATL cells across AITO line with 1.2M+ deliveries, advances 'Plant in Plant' Phase 2 to 10–12 GWh, and adds supercharging, battery services and overseas expansion.
10 October 2026

Genentech: One-year Phase III data for vamikibart in uveitic macular edema

Vamikibart showed sustained vision gains and reduced macular thickness at 52 weeks in MEERKAT and SANDCAT; FDA has accepted the BLA with a decision due by July 2027.
10 October 2026

Merck: BRUNELLO one-year data — remigromig non-inferior to ranibizumab in DME

Remigromig met non-inferiority for mean BCVA change versus monthly ranibizumab at one year in DME; higher rates of PDR-related adverse events and discontinuations were reported.
9 October 2026

East Grain CEO Tamás Vincze on supply-chain focus, AGROFERT ties and expansion

CEO explains pivot from commodity trading to supply-chain integration, silo and feed investments, Maragro acquisition and recruitment ties to Cluj universities.
9 October 2026

Equinor and Shell partner on Bay du Nord; Shell takes 30% stake

Transaction supports maturation toward an early‑2027 investment decision; operator retains 70% and FPSO-based development in the Flemish Pass continues.
9 October 2026

EMA recommends Intervet's Bovilis Lumpyvax for lumpy skin disease

Live attenuated vaccine cuts clinical signs and viraemia from three weeks post‑vaccination and confers protection for one year; authorised under exceptional circumstances; side effects are uncommon.
9 October 2026

CVMP meeting highlights — 6–8 Oct 2026

Positive opinions for Bovilis Lumpyvax and Stemyca; Mirataz SPC updated for overdose effects; Vaxxitek MA extended one year; Vetmedin re‑examination concluded positive by majority.
9 October 2026

Arkema showcases battery material solutions at US Battery Show 2026

Highlights binders, PVDF and thermal/safety materials for EV and stationary batteries; 15% PVDF capacity expansion completed in June 2026; visit Booth #2714 Oct 12–15 in Detroit.
9 October 2026

Aurora delivers first pyrolysis bio-oil from Empyro

First load of pyrolysis bio-oil delivered to FrieslandCampina for co-firing in industrial steam boilers, partially replacing natural gas.
9 October 2026

Eli Lilly: Taltz plus Zepbound show broader immunometabolic biomarker changes in TOGETHER‑PsO

Combination therapy produced broader psoriasis-related and metabolic biomarker changes vs Taltz alone as early as Week 12, with greater reductions in inflammatory and neutrophil markers.
9 October 2026

Johnson & Johnson ICOTYDE delivers durable 2‑year plaque psoriasis results

Phase 3 data show sustained PASI90/PASI100 and IGA 0/1 responses to Week 112, durable itch improvement, and no new safety signals.
9 October 2026

Sinopec Beidou oil and gas field technology and terminal R&D project passes MIIT acceptance

MIIT accepted a 'one-stop' Beidou tech and terminal R&D demonstration for oil and gas that produced 8 product categories, 34 terminals and is deployed across 104 enterprises.
9 October 2026

Asahi Kasei Therapeutics doses first patient in Phase 2a trial of AIC468 for BK virus

First patient dosed in a randomized Phase 2a trial of AIC468, an antisense oligonucleotide targeting BK virus in adult kidney transplant recipients.
8 October 2026

Nouryon news and press releases

Regulatory clearance in China to supply a plant-based, water‑soluble pharmaceutical ingredient; India operations re-certified Great Place To Work for a second consecutive year.
8 October 2026

Genentech: FDA approves Tecentriq plus fluoropyrimidine and oxaliplatin as adjuvant for stage III dMMR colon cancer

FDA backs first adjuvant immunotherapy regimen for stage III dMMR colon cancer after ATOMIC showed a 50% reduction in recurrence or death with Tecentriq added to chemotherapy.
8 October 2026

Koch Technology Solutions and Alpek sign license for Suape PTA steam-reduction retrofit

License-backed retrofit to cut steam consumption, improve energy efficiency and competitiveness at the Suape PTA plant; moves to Process Design Package after a feasibility study.
8 October 2026

ProLogium unveils DCN third lithium‑ion transport mechanism (SFIE)

Introduces a Dynamic Coordination Network using a Superfluidized Inorganic Electrolyte to enable a third ion‑transport mode and fast‑charging automotive applications.
8 October 2026

Aptar expands pharma manufacturing in Mumbai

Adds local production of pMDI valves, breath‑actuated inhalation devices and multi dose nasal spray systems; site grows to 11,300 m² to improve regional supply resilience.
8 October 2026

BASF launches GLYTHERMIN® coolants for liquid‑cooled data centers

Propylene‑glycol heat‑transfer fluids for direct liquid cooling; DC PG25 is NVIDIA DSX Ready Coolant; BASF cites backward integration for supply reliability and corrosion protection tech.
8 October 2026

Rompetrol Rafinare to install 9.4 MW PV plant at Petromidia refinery

9.4 MW PV at Petromidia to supply >9,800 MWh/year for internal use, cut ~6,024 tCO2/year; project cost ~44 million lei with 14 million lei EU Modernization Fund grant; completion by 31 Dec 2028.
8 October 2026

QatarEnergy and Petrobras secure seven Ceará Basin exploration blocks

Seven deepwater exploration blocks in Brazil’s Ceará Basin (≈4,700 km²; 2,000–3,600 m depths) awarded in ANP’s 6th concession round; contracts expected H1 2027.
8 October 2026

Equinor gas discovery at Gullfaks South

Gas found at Gullfaks South: 0.5–1.6 million standard cubic metres of recoverable oil equivalents (3.3–10.3 million boe), drilled as a sidetrack to a production well.
8 October 2026

Bayer’s finerenone sNDA accepted by FDA for CKD without diabetes

FDA acceptance of finerenone sNDA for adults with CKD without diabetes follows Phase III FIND‑CKD showing slower eGFR decline and reduced cardio‑kidney events versus placebo.
8 October 2026

argenx discontinues Phase 3 UNITY trial of efgartigimod SC in Sjögren's disease

Independent Data Monitoring Committee advised stopping the trial for futility after an interim analysis; safety remained consistent and no new signals were seen.
8 October 2026

argenx: Phase 2 shows FB102 protects intestine in celiac disease

FB102, a CD122 inhibitor, met the primary histology endpoint (Vh:Cd change; p=0.0176) versus placebo and showed aligned symptom and inflammatory benefits with no new safety signals.